Paper21472018
Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.
Pode-Shakked N and 11 others. Oncogene, 2011. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target. Papers, record 21472018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21472018
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Frizzled Receptors | Major topic |
| Kidney Neoplasms | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Wilms Tumor | Major topic |
| Wnt Proteins | Major topic |
| Adaptor Proteins, Signal Transducing | |
| Antibodies, Monoclonal | |
| Ataxia Telangiectasia Mutated Proteins | |
| Cell Cycle Proteins | |
| Flow Cytometry | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Intercellular Signaling Peptides and Proteins | |
| Mutation | |
| Protein Serine-Threonine Kinases | |
| Tumor Cells, Cultured | |
| Tumor Suppressor Proteins | |
| beta Catenin |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15372092 | WNT and beta-catenin signalling: diseases and therapies. | Nat Rev Genet | 2004 | https://conductscience.org/library/papers/15372092 | PubMed |
| 2 | 19496704 | Value and difficulties of a common European strategy for recurrent Wilms' tumor. | Expert Rev Anticancer Ther | 2009 | https://conductscience.org/library/papers/19496704 | PubMed |
| 3 | 12781368 | Caught up in a Wnt storm: Wnt signaling in cancer. | Biochim Biophys Acta | 2003 | https://conductscience.org/library/papers/12781368 | PubMed |
| 4 | 18283316 | Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18283316 | PubMed |
| 5 | 16575872 | Target genes of the WNT/beta-catenin pathway in Wilms tumors. | Genes Chromosomes Cancer | 2006 | https://conductscience.org/library/papers/16575872 | PubMed |
| 6 | 18537968 | Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. | Br J Haematol | 2008 | https://conductscience.org/library/papers/18537968 | PubMed |
| 7 | 15942996 | The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer. | Minn Med | 2005 | https://conductscience.org/library/papers/15942996 | PubMed |
| 8 | 18467665 | Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. | Stem Cells | 2008 | https://conductscience.org/library/papers/18467665 | PubMed |
| 9 | 12710691 | Wilms' tumor as a model for cancer biology. | Methods Mol Biol | 2003 | https://conductscience.org/library/papers/12710691 | PubMed |
| 10 | 17093069 | Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/17093069 | PubMed |
| 11 | 16529553 | Cancer stem cells and therapeutic perspectives. | Curr Med Chem | 2006 | https://conductscience.org/library/papers/16529553 | PubMed |
| 12 | 19005674 | Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. | Histochem Cell Biol | 2008 | https://conductscience.org/library/papers/19005674 | PubMed |
| 13 | 17634527 | WNT signaling pathway and stem cell signaling network. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17634527 | PubMed |
| 14 | 17537789 | Wnt/beta-catenin signaling regulates nephron induction during mouse kidney development. | Development | 2007 | https://conductscience.org/library/papers/17537789 | PubMed |
| 15 | 10463574 | Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. | Cancer Res | 1999 | https://conductscience.org/library/papers/10463574 | PubMed |
| 16 | 17051156 | Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. | Nature | 2006 | https://conductscience.org/library/papers/17051156 | PubMed |
| 17 | 10075850 | Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. | Dev Biol | 1999 | https://conductscience.org/library/papers/10075850 | PubMed |
| 18 | 14522905 | Identification of a cancer stem cell in human brain tumors. | Cancer Res | 2003 | https://conductscience.org/library/papers/14522905 | PubMed |
| 19 | 17157167 | A novel and rapid in vivo system for testing therapeutics on human leukemias. | Exp Hematol | 2006 | https://conductscience.org/library/papers/17157167 | PubMed |
| 20 | 18260125 | New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. | Genes Chromosomes Cancer | 2008 | https://conductscience.org/library/papers/18260125 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41899513 | Tumor Microenvironment and Immune Response Against Wilms Tumor: Evasion Mechanisms and Implications for Immunotherapeutic Approaches. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899513 | PubMed |
| 41218118 | FZD7 expression marks mammary tumor-initiating cells. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41218118 | PubMed |
| 41211430 | Role of EMT in drug resistance of breast cancer: molecular mechanisms and therapeutic strategies. | Front Oncol | 2025 | https://conductscience.org/library/papers/41211430 | PubMed |
| 41069407 | A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41069407 | PubMed |
| 39766864 | Wnt Signaling Pathway in Tumor Biology. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39766864 | PubMed |
| 38929279 | Wnt/β-Catenin Signaling Pathway in Pediatric Tumors: Implications for Diagnosis and Treatment. | Children (Basel) | 2024 | https://conductscience.org/library/papers/38929279 | PubMed |
| 38632318 | Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers. | Acta Pharmacol Sin | 2024 | https://conductscience.org/library/papers/38632318 | PubMed |
| 38559981 | FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. | ACS Omega | 2024 | https://conductscience.org/library/papers/38559981 | PubMed |
| 37310573 | Synthesis of the scFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study. | Clin Transl Oncol | 2024 | https://conductscience.org/library/papers/37310573 | PubMed |
| 36620565 | Frizzled receptors in melanomagenesis: From molecular interactions to target identification. | Front Oncol | 2022 | https://conductscience.org/library/papers/36620565 | PubMed |
| 36276155 | Antitumor effect and mechanism of FZD7 polypeptide vaccine. | Front Oncol | 2022 | https://conductscience.org/library/papers/36276155 | PubMed |
| 35399726 | Mir-454-3p induced WTX deficiency promotes hepatocellular carcinoma progressions through regulating TGF-β signaling pathway. | J Cancer | 2022 | https://conductscience.org/library/papers/35399726 | PubMed |
| 35334792 | Exosomal FZD-7 Expression Is Modulated by Different Lifestyle Interventions in Patients with NAFLD. | Nutrients | 2022 | https://conductscience.org/library/papers/35334792 | PubMed |
| 34463852 | An Overview of Potential Therapeutic Agents Targeting WNT/PCP Signaling. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/34463852 | PubMed |
| 34463849 | Pharmacologically Targeting the WNT/β-Catenin Signaling Cascade: Avoiding the Sword of Damocles. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/34463849 | PubMed |
| 34455486 | Frizzled7 Activates β-Catenin-Dependent and β-Catenin-Independent Wnt Signalling Pathways During Developmental Morphogenesis: Implications for Therapeutic Targeting in Colorectal Cancer. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/34455486 | PubMed |
| 34455485 | Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/34455485 | PubMed |
| 33436039 | A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33436039 | PubMed |
| 33374459 | Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33374459 | PubMed |
| 32998794 | Frizzled Receptors in Tumors, Focusing on Signaling, Roles, Modulation Mechanisms, and Targeted Therapies. | Oncol Res | 2021 | https://conductscience.org/library/papers/32998794 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AMER1 | 139285 | PubTator's text mining | https://conductscience.org/library/genes/139285 | NCBI Gene |
| ATR | 545 | PubTator's text mining | https://conductscience.org/library/genes/545 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| DKK1 | 22943 | PubTator's text mining | https://conductscience.org/library/genes/22943 | NCBI Gene |
| FZD7 | 8324 | PubTator's text mining | https://conductscience.org/library/genes/8324 | NCBI Gene |
| SFRP1 | 6422 | PubTator's text mining | https://conductscience.org/library/genes/6422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21472018
GET https://conductscience.org/api/papers/v1/21472018/references?page=2